Showing 41 - 60 results of 124 for search '"osteosarcoma"', query time: 0.06s Refine Results
  1. 41

    Integrins identified as potential prognostic markers in osteosarcoma through multi-omics and multi-dataset analysis by Lei Cui, Shuai Zhao, Hai long Teng, Biao Yang, Qian Liu, An Qin

    Published 2025-01-01
    “…Abstract Osteosarcoma represents 20% of primary malignant bone tumors globally. …”
    Get full text
    Article
  2. 42

    Identification of Common Oncogenic Genes and Pathways Both in Osteosarcoma and Ewing’s Sarcoma Using Bioinformatics Analysis by Jingwei Zhang, Junchao Huang, Wenjun Liu, Liang Ding, Dongdong Cheng, Haijun Xiao

    Published 2022-01-01
    “…This study was aimed at exploring common oncogenic genes and pathways both in osteosarcoma and Ewing’s sarcoma. Microarray data were obtained from the Gene Expression Omnibus (GEO) database. …”
    Get full text
    Article
  3. 43

    Association of JMJD2B and Hypoxia-Inducible Factor 1 Expressions with Poor Prognosis in Osteosarcoma by Xujian Liu, Qianqian Zhang, Yi Zhao, Jianjun Xun, Hongzeng Wu, Helin Feng

    Published 2020-01-01
    “…This study is aimed at exploring the expression and prognostic significance of JMJD2B in osteosarcoma and its association with hypoxia-inducible factor 1 (HIF1). …”
    Get full text
    Article
  4. 44
  5. 45
  6. 46
  7. 47

    The Value of Immune-Related Genes Signature in Osteosarcoma Based on Weighted Gene Co-expression Network Analysis by Xin Wang, Li Gan, Ju Ye, Mengjie Tang, Wei Liu

    Published 2021-01-01
    “…Background. Osteosarcoma (OS) is a serious malignant tumor that is more common in adolescents or children under 20 years of age. …”
    Get full text
    Article
  8. 48

    Systemic Inflammatory Markers for Predicting Overall Survival in Patients with Osteosarcoma: A Systematic Review and Meta-Analysis by Xiaotong Song, Hao Zhang, Fanxing Yin, Panpan Guo, Xiaocheng Yang, Jinzhu Liu, Yanshuo Han, Zhaozhou Ren

    Published 2021-01-01
    “…Inflammatory markers are associated with tumor genesis and progression, but their prognostic significance in osteosarcoma remains unclear. Therefore, we discussed the prognostic value of related inflammatory markers in osteosarcoma through a meta-analysis and systematic review. …”
    Get full text
    Article
  9. 49
  10. 50
  11. 51
  12. 52
  13. 53
  14. 54
  15. 55
  16. 56

    Long-term Outcome of Vascularized Fibular Bone Graft Reconstruction for Upper Limb Osteosarcoma: A Case Report by Revanth Thiruvarul Selvan, Gutta Charith, Viveksheel Bhatti, Gopinath Menon

    Published 2024-06-01
    “…Introduction: Osteosarcoma is a primary malignant bone tumor. In older days, the mainstay treatment was used to be amputation of the affected extremity. …”
    Get full text
    Article
  17. 57

    A Rare Extraskeletal Osteosarcoma Appearing After 55 Years on a Large Stage 3 Burn Scar by O. Vanhooteghem, I. Theate

    Published 2018-01-01
    “…Fifty-five years after the injury, this patient developed a large extraosseous osteosarcoma on the scar.…”
    Get full text
    Article
  18. 58

    Content Determination of Active Component in Huangqi Yinyanghuo Group and Its Effects on hTERT and Bcl-2 Protein in Osteosarcoma by Ying Tan, Lei Tan, Shuai Huang, Junfan Lu, Longtan Yu

    Published 2014-01-01
    “…To screen the optimal extraction process and content determination of active component of Huangqi Yinyanghuo group (HYG) and to study the effects of HYG on human telomerase reverse transcriptase (hTERT) and Bcl-2 protein in osteosarcoma (HOS) cells, providing the theoretical basis for clinical application of HYG in treatment of osteosarcoma, orthogonal design table L9(43) was used to design the extraction process of HYG, and icariin was taken as the investigation index to optimize the extraction process of HYG. 0.125, 0.25, 0.5, 1, 2, 4, and 8 μmol/L HYG were taken to act separately on logarithmic growth phase osteosarcoma HOS cells, CCK-8 assay was used to determine cell viability, and immunohistochemical SP assay was used to determine the expression of hTERT and Bcl-2 protein. …”
    Get full text
    Article
  19. 59

    Fabrication of a Porous Metal-Organic Framework with Polar Channels for 5-Fu Delivery and Inhibiting Human Osteosarcoma Cells by Li-Chun Zhao, Mei Tang, Qian-Hua Zhang, Zhi-Yi Hu, Hong-Wei Gao, Xia-Yun Liao, Gang Wang, Jing Leng

    Published 2018-01-01
    “…Furthermore, as indicated by the MTT assay, this drug/MOF composite shows low toxicity toward the human normal cells and demonstrates obvious anticancer activity against the human osteosarcoma cell line MG63.…”
    Get full text
    Article
  20. 60